Walleye Capital
ITCI icon

Walleye Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Walleye Capital’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,600
Closed -$629K – 5756
2024
Q3 		$629K Sell
8,600
-2,300
-21% -$173K ﹤0.01% 3081
2024
Q2 		$747K Buy
10,900
+10,500
+2,625% +$728K ﹤0.01% 3126
2024
Q1 		$27.7K Sell
400
-600
-60% -$41.2K ﹤0.01% 4838
2023
Q4 		$71.6K Buy
1,000
+100
+11% +$5.75K ﹤0.01% 4185
2023
Q3 		$46.9K Hold
900
– – ﹤0.01% 4209
2023
Q2 		$57K Buy
900
+500
+125% +$31.2K ﹤0.01% 3614
2023
Q1 		$21.7K Sell
400
-9,500
-96% -$459K ﹤0.01% 3391
2022
Q4 		$524K Sell
9,900
-10,300
-51% -$516K 0.01% 1421
2022
Q3 		$940K Buy
+20,200
New +$1.06M 0.02% 1025
2020
Q1 		– Sell
-116,400
Closed -$3.99M – 1804
2019
Q4 		$3.99M Buy
116,400
+38,100
+49% +$457K 0.26% 73
2019
Q3 		$585K Buy
+78,300
New +$751K 0.03% 679
2019
Q2 		– Sell
-1,000
Closed -$12K – 2132
2019
Q1 		$12K Buy
+1,000
New +$12.8K ﹤0.01% 1394

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pentwater Capital Management
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HBK Investments
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Davidson Kempner Capital Management
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Walleye Capital's ITCI Position: Q1 2025 in Review

Walleye Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 383,591 shares — an estimated $32M sold.

Walleye Capital first reported a position in ITCI in Q1 2019 and held it in 18 quarters. The position peaked at $32M in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Walleye Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 383,591 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $32M.
  • Walleye Capital first reported a position in Intra-Cellular Therapies Inc. in Q1 2019 and held it in 18 quarters.
  • Walleye Capital's Intra-Cellular Therapies Inc. position peaked at $32M in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.